These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14052139)

  • 21. Pertussis vaccination and whooping cough: and now what?
    Guiso N
    Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Restriction analysis of Bordetella pertussis DNA isolated from patients with whooping cough in 1968 and 1995-98 and B. pertussis used for production of national vaccine strains].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 2000; 52(2):111-7. PubMed ID: 11107785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of hyperimmune gamma globulin to prevent whooping cough.
    MORRIS D; MCDONALD JC
    Arch Dis Child; 1957 Jun; 32(163):236-9. PubMed ID: 13445306
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of an acellular pertussis vaccine among adolescents and adults.
    Ward JI; Cherry JD; Chang SJ; Partridge S; Lee H; Treanor J; Greenberg DP; Keitel W; Barenkamp S; Bernstein DI; Edelman R; Edwards K;
    N Engl J Med; 2005 Oct; 353(15):1555-63. PubMed ID: 16221778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of whooping cough complications in 1963].
    Gawrychowski S
    Przegl Epidemiol; 1965; 19(2):162-3. PubMed ID: 4160687
    [No Abstract]   [Full Text] [Related]  

  • 26. [EXPERIENCES WITH ACTIVE PREVENTIVE IMMUNIZATION AGAINST WHOOPING COUGH].
    PASCHLAU G
    Offentl Gesundheitsdienst; 1965 Apr; 27():123-31. PubMed ID: 14308505
    [No Abstract]   [Full Text] [Related]  

  • 27. Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines.
    Lancet; 1988 Apr; 1(8592):955-60. PubMed ID: 2896826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.
    Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B
    Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemiological situation of pertussis in the Federal Republic of Germany.
    Finger H; Wirsing von König CH; Tacken A; Wassilak SG
    Dev Biol Stand; 1991; 73():343-55. PubMed ID: 1778329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Secondary whooping cough after the first dose of mixed diphtheria-whooping cough vaccine].
    RUIZ UBEDA M
    Rev Esp Pediatr; 1951; 7(4):503-9. PubMed ID: 14883524
    [No Abstract]   [Full Text] [Related]  

  • 31. Whooping-cough vaccine.
    BAYLY MB
    Med World; 1947 Jan; 65(21):653-5. PubMed ID: 20278767
    [No Abstract]   [Full Text] [Related]  

  • 32. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
    Ward JI; Cherry JD; Chang SJ; Partridge S; Keitel W; Edwards K; Lee M; Treanor J; Greenberg DP; Barenkamp S; Bernstein DI; Edelman R;
    Clin Infect Dis; 2006 Jul; 43(2):151-7. PubMed ID: 16779740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antigens of Bordetella pertussis and their repercussion in immunization programs against whooping cough].
    Casal Lombos J
    Rev Sanid Hig Publica (Madr); 1971 May; 45(5):575-87. PubMed ID: 4330706
    [No Abstract]   [Full Text] [Related]  

  • 34. As immunity wanes, whooping cough returns.
    Chin TL
    Health Aff (Millwood); 2014 Dec; 33(12):2095-8. PubMed ID: 25489026
    [No Abstract]   [Full Text] [Related]  

  • 35. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CONTEMPORARY PROBLEMS IN THE EPIDEMIOLOGY OF WHOOPING COUGH.
    VYSOKA BURIANOVA B
    J Hyg Epidemiol Microbiol Immunol; 1963; 7():472-81. PubMed ID: 14114942
    [No Abstract]   [Full Text] [Related]  

  • 37. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
    Bouchez V; Guiso N
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of Bordetella holmesii as a Causative Agent of Whooping Cough, Barcelona, Spain.
    Mir-Cros A; Codina G; Martín-Gómez MT; Fàbrega A; Martínez X; Jané M; Van Esso D; Cornejo T; Rodrigo C; Campins M; Pumarola T; González-López JJ
    Emerg Infect Dis; 2017 Nov; 23(11):1856-1859. PubMed ID: 29052540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pertussis (Whooping cough)--an update].
    Stock I
    Med Monatsschr Pharm; 2015 Dec; 38(12):484-8. PubMed ID: 26837155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Whooping cough--therapy and prevention].
    Rabo E
    Lakartidningen; 1977 Apr; 74(14):1386-9. PubMed ID: 66423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.